Skip to main content
ADVANCED SEARCH
Log in
Top

Advances in Therapy

Issue 6/2025

Content (28 Articles)

An Expert Opinion on Current and Future Treatment Approaches in IgA Nephropathy

Richard J. Glassock

The Limitations of Artificial Intelligence in Head and Neck Oncology

Karthik N. Rao, Veronica Fernandez-Alvarez, Orlando Guntinas-Lichius, M. P. Sreeram, Remco de Bree, Luiz P. Kowalski, Arlene Forastiere, Pia Pace-Asciak, Juan P. Rodrigo, Nabil F. Saba, Ohad Ronen, Ewa Florek, Gregory W. Randolph, Alvaro Sanabria, Jan B. Vermorken, Ehab Y. Hanna, Alfio Ferlito

Improving Care for People with Chronic Respiratory Diseases: Taking a Policy Lens

Aislinn Santoni, Suzanne Wait, Job F. M. van Boven, Zachary Desson, Christine Jenkins, Ee Ming Khoo, Tonya Winders, Dawei Yang, Arzu Yorgancioglu

Lidocaine—A Promising Candidate for the Treatment of Cancer-Induced Bone Pain: A Narrative Review

Lihan Luo, Yuqi Cheng, Hanxi Wang, Li Li, Hanyun Niu, Yuzhu Yang, Qianqian Zhou, Jiannan He, Jianhong Xu

Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment

Carla Rognoni, Robert Pohlmeier, Rosanna Tarricone

Current Situation and Prospects of Digital Therapeutics in the Field of Liver Diseases in China

Junfeng Chen, Shaoquan Zhang, Xian Cao, Dili Daer, Bingliang Lin

Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments

Kazi Islam, Rahib Islam, Ivan Nguyen, Hassan Malik, Humza Pirzadah, Barsha Shrestha, Isabella B. Lentz, Sahar Shekoohi, Alan D. Kaye

Efficacy of Biologics in Reducing Exacerbations Requiring Hospitalization or an Emergency Department Visit in Patients with Moderate or Severe, Uncontrolled Asthma

Reynold A. Panettieri Jr., Monica Kraft, Mario Castro, Magdalena Bober, Andrew W. Lindsley, Max Shelkrot, Christopher S. Ambrose

Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison

Marcin Dzienis, Ali Mojebi, Sam Keeping, Christopher M. Black, Hilde Giezek, Niroshini Naicker, Chiara Vanetta, Julie E. Park, Keith Chan, Sanjay Merchant, Dandan Zheng

One-Year Efficacy of Guselkumab Versus Advanced Therapies for the Treatment of Moderately to Severely Active Crohn’s Disease: A Network Meta-Analysis

Tim Disher, Dominik Naessens, Myrlene Sanon, Ashley Bonner, Jenna Ellis, Meaghan Bartlett, Becky Hooper, Zijiang Yang, Jessica R. Allegretti, Axel Dignass

Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study

Matthias Augustin, Esther Serra-Baldrich, Julien Seneschal, Susanne Grond, Anastasia Lampropoulou, Mohamed Elrayes, Samuel Ogwu, Inmaculada de la Torre, Anthony Bewley, Andreas Pinter

Assessment of Access Barriers to Rifaximin Among Patients with Hepatic Encephalopathy Using Adjudicated Claims Data

Arun Jesudian, Patrick Gagnon-Sanschagrin, Jessica Maitland, Kana Yokoji, Annie Guérin, Zeev Heimanson, Aaron Samson, Olamide Olujohungbe, Brock Bumpass

Validation of an Administrative Claims-based Line of Therapy Algorithm for Women with Ovarian Cancer Using Medical Chart Review

Daniel Simmons, John White, Valery Walker, Stephanie V. Blank, Jiefen Munley, Kimmie McLaurin

A Cost-Effectiveness Analysis of Abemaciclib in Combination with Adjuvant Endocrine Therapy for HR+, HER2–, Node-Positive, High-Risk Early Breast Cancer

Alison Davie, Sory Traoré, Waleed Badreldin, Astrid Torstensson, Esra Cakar, Anuja C. McCullough, Susan Tempelaar, Elisabeth Fenwick, Peter S. Hall

Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer

  • NSCLC
  • Original Research

Manasee V. Shah, Caitlyn T. Solem, Kelly F. Bell, Amine Aziez, Xuezheng Sun, Mandy Du, Ella X. Du, Hongbo Yang, Hongjue Wang, Qi Hua, Umit Tapan

A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects

Jia Xu, Junyou Ge, Yaling Li, Shulin Liu, Sicong Li, Jing Si, Juncheng Liu, Xiaoxue Zhu, Yanhua Ding

Incidence and Prevalence of Chronic Spontaneous Urticaria Among Adult and Pediatric Populations in the United States

Yvonne Geissbühler, Maria M. Balp, Aine McConnon, Justin Gomme, Sarah J. McKenna, Ravneet K. Kohli, Weily Soong

Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study

Marc Evans, William Evans, Fiona Godbeer, Laurienne Edgar, Erik Spaepen, Alun Lloyd Davies

Co-treatment with Gabapentinoid and Japanese Herbal Medicine Goshajinkigan for CIPN is Associated with Longer Duration and Higher Dose of Chemotherapy

Kanako Miyano, Yasuhito Uezono, Takuhiro Yamaguchi, Wataru Hashimoto, Satoshi Komoriya

Prevalence, Treatment Patterns, and Characteristics of US Adults with Confirmed or at Risk for Growth Hormone Deficiency

Andrew R. Hoffman, Subhara Raveendran, Janna Manjelievskaia, Allison S. Komirenko, Isabelle Winer, Jennifer Cheng, Machaon Bonafede, Jessamine P. Winer-Jones, Paul Miner, Alden R. Smith

LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area

Liming Zhao, Jiamei Liu, Yin Liu, Zhenna Huang, Xuxiao Ye, Jeff L. Lange, Nafeesa Dhalwani, Fan Yang, Zizhao Zhang, Kangyin Chen, Hao Zhang, Jifang Zhou

Cost-Effectiveness Analysis of SGLT2 Inhibitors for Cardio-Renal-Metabolic Disease Based on Data from Japanese Studies

Ataru Igarashi, Hisateru Tachimori, Keiko Maruyama-Sakurai, Yasumasa Segawa, Hiroyuki Takagi, Hiroki Akiyama, Naohiko Imai, Shun Kohsaka, Hiroaki Miyata

Improving Clinical Management and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis in China via Real-world Evidence (IMPROVE Study): A Multicenter Prospective Cohort Study

Nan Jiang, Dongzhou Liu, Xinwang Duan, Lijun Wu, Yi Liu, Hao Zhu, Yanjie Zhang, Mengtao Li, Xinping Tian, Xiaofeng Zeng

The Impacts of Caregiving for Patients with X-Linked Retinitis Pigmentosa (XLRP): Findings from the EXPLORE XLRP-2 Study

Michel Weber, Francesco Parmeggiani, Dominique Bremond-Gignac, Avril Daly, Marjolein Lahaye, Andrew Lotery, Nabin Paudel, Markus Ritter, Enrique Rodríguez de la Rúa, Ygal Rotenstreich, Eeva-Marja Sankila, Katarina Stingl, Jacqueline Van Denderen, Tom Denee, Katalin Pungor

Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis

Lijuan Deng, Yuqin Song, Keshu Zhou, Dengju Li, Jianda Hu, Dehui Zou, Sujun Gao, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Ru Feng, Jie Jin, Fangfang Lv, Cheng Fang, Sheng Xu, Jun Zhu

The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and Obesity

Alan Kaplan, Heath Heatley, John Townend, Derek Skinner, Victoria Carter, Richard Hubbard, Tan Tze Lee, Mariko Siyue Koh, David Price

Long-Term Efficacy and Safety of Growth Hormone in Children Suffering from Short Stature in China (CGLS): An Open-Label, Multicenter, Prospective and Retrospective, Observational Study

Wei Wu, Xiaoping Luo

Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review

Piotr Wiland, Charlotte Both, Norman B. Gaylis, Russell D. Cohen, Jonas Halfvarson, Lena Lemke, Oliver von Richter, Andrew Blauvelt

May 25
Issue: 5/2025

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more
Image Credits